| Andrew J Zielinski, CRNA | |
|
2809 Denny Ave, Pascagoula, MS 39581-5301 | |
| (228) 809-5540 | |
| (228) 809-1153 |
| Full Name | Andrew J Zielinski |
|---|---|
| Gender | Male |
| Speciality | Certified Registered Nurse Anesthetist (crna) |
| Experience | 27 Years |
| Location | 2809 Denny Ave, Pascagoula, Mississippi |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1073558185 | NPI | - | NPPES |
| 03833522 | Medicaid | MS | |
| 709143 | Other | MS | MEDICARE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 367500000X | Nurse Anesthetist, Certified Registered | 887792 (Mississippi) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Singing River Health System | Pascagoula, MS | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Singing River Health System | 3870405194 | 156 |
News Archive
TetraLogic Pharmaceuticals announced today that the Company has completed dosing of the first cohort in a Phase 1 clinical trial of its selective SMAC mimetic, TL32711. The Phase 1 trial is an open-label, dose-escalation study evaluating the safety and tolerability of TL32711 in adults with solid tumors or lymphoma refractory to standard therapies. The study will also assess the pharmacokinetics, pharmacodynamics and anti-tumor activity of TL32711.
Ovarian cancer is the most deadly disease of the female reproductive system, with most cases diagnosed in later stages. Yet while ovarian cancer affects 1 in 70 women in the United States, many women have never discussed the risk with their doctor.
GOP Presidential hopeful Rick Santorum continued to press the parallels between the state law signed by his rival, former Massachusetts Gov. Mitt Romney, and the federal measure, as well as to question Romney's explanation of his positions. Meanwhile, news outlets report on how the gender gap and social issues like contraception are playing in this election cycle.
In an unprecedented show of concern, The Academy for Eating Disorders (AED), Binge Eating Disorder Association (BEDA), Eating Disorder Coalition (EDC), International Association for Eating Disorder Professionals (IADEP), and National Eating Disorder Association (NEDA) have joined forces and are urging focus on health and lifestyle rather than weight as a measurement of well-being.
› Verified 9 days ago
| Entity Name | Singing River Health System |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1083893937 PECOS PAC ID: 3870405194 Enrollment ID: O20031104000435 |
News Archive
TetraLogic Pharmaceuticals announced today that the Company has completed dosing of the first cohort in a Phase 1 clinical trial of its selective SMAC mimetic, TL32711. The Phase 1 trial is an open-label, dose-escalation study evaluating the safety and tolerability of TL32711 in adults with solid tumors or lymphoma refractory to standard therapies. The study will also assess the pharmacokinetics, pharmacodynamics and anti-tumor activity of TL32711.
Ovarian cancer is the most deadly disease of the female reproductive system, with most cases diagnosed in later stages. Yet while ovarian cancer affects 1 in 70 women in the United States, many women have never discussed the risk with their doctor.
GOP Presidential hopeful Rick Santorum continued to press the parallels between the state law signed by his rival, former Massachusetts Gov. Mitt Romney, and the federal measure, as well as to question Romney's explanation of his positions. Meanwhile, news outlets report on how the gender gap and social issues like contraception are playing in this election cycle.
In an unprecedented show of concern, The Academy for Eating Disorders (AED), Binge Eating Disorder Association (BEDA), Eating Disorder Coalition (EDC), International Association for Eating Disorder Professionals (IADEP), and National Eating Disorder Association (NEDA) have joined forces and are urging focus on health and lifestyle rather than weight as a measurement of well-being.
› Verified 9 days ago
| Entity Name | Jackson County Anesthesia |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1922159219 PECOS PAC ID: 9931292729 Enrollment ID: O20070913000898 |
News Archive
TetraLogic Pharmaceuticals announced today that the Company has completed dosing of the first cohort in a Phase 1 clinical trial of its selective SMAC mimetic, TL32711. The Phase 1 trial is an open-label, dose-escalation study evaluating the safety and tolerability of TL32711 in adults with solid tumors or lymphoma refractory to standard therapies. The study will also assess the pharmacokinetics, pharmacodynamics and anti-tumor activity of TL32711.
Ovarian cancer is the most deadly disease of the female reproductive system, with most cases diagnosed in later stages. Yet while ovarian cancer affects 1 in 70 women in the United States, many women have never discussed the risk with their doctor.
GOP Presidential hopeful Rick Santorum continued to press the parallels between the state law signed by his rival, former Massachusetts Gov. Mitt Romney, and the federal measure, as well as to question Romney's explanation of his positions. Meanwhile, news outlets report on how the gender gap and social issues like contraception are playing in this election cycle.
In an unprecedented show of concern, The Academy for Eating Disorders (AED), Binge Eating Disorder Association (BEDA), Eating Disorder Coalition (EDC), International Association for Eating Disorder Professionals (IADEP), and National Eating Disorder Association (NEDA) have joined forces and are urging focus on health and lifestyle rather than weight as a measurement of well-being.
› Verified 9 days ago
| Entity Name | Singing River Gulfport |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1861010159 PECOS PAC ID: 5294154829 Enrollment ID: O20201001001497 |
News Archive
TetraLogic Pharmaceuticals announced today that the Company has completed dosing of the first cohort in a Phase 1 clinical trial of its selective SMAC mimetic, TL32711. The Phase 1 trial is an open-label, dose-escalation study evaluating the safety and tolerability of TL32711 in adults with solid tumors or lymphoma refractory to standard therapies. The study will also assess the pharmacokinetics, pharmacodynamics and anti-tumor activity of TL32711.
Ovarian cancer is the most deadly disease of the female reproductive system, with most cases diagnosed in later stages. Yet while ovarian cancer affects 1 in 70 women in the United States, many women have never discussed the risk with their doctor.
GOP Presidential hopeful Rick Santorum continued to press the parallels between the state law signed by his rival, former Massachusetts Gov. Mitt Romney, and the federal measure, as well as to question Romney's explanation of his positions. Meanwhile, news outlets report on how the gender gap and social issues like contraception are playing in this election cycle.
In an unprecedented show of concern, The Academy for Eating Disorders (AED), Binge Eating Disorder Association (BEDA), Eating Disorder Coalition (EDC), International Association for Eating Disorder Professionals (IADEP), and National Eating Disorder Association (NEDA) have joined forces and are urging focus on health and lifestyle rather than weight as a measurement of well-being.
› Verified 9 days ago
| Entity Name | Singing River Health System |
|---|---|
| Entity Type | Part B Supplier - Hospital Department(s) |
| Entity Identifiers | NPI Number: 1740918937 PECOS PAC ID: 3870405194 Enrollment ID: O20221202000423 |
News Archive
TetraLogic Pharmaceuticals announced today that the Company has completed dosing of the first cohort in a Phase 1 clinical trial of its selective SMAC mimetic, TL32711. The Phase 1 trial is an open-label, dose-escalation study evaluating the safety and tolerability of TL32711 in adults with solid tumors or lymphoma refractory to standard therapies. The study will also assess the pharmacokinetics, pharmacodynamics and anti-tumor activity of TL32711.
Ovarian cancer is the most deadly disease of the female reproductive system, with most cases diagnosed in later stages. Yet while ovarian cancer affects 1 in 70 women in the United States, many women have never discussed the risk with their doctor.
GOP Presidential hopeful Rick Santorum continued to press the parallels between the state law signed by his rival, former Massachusetts Gov. Mitt Romney, and the federal measure, as well as to question Romney's explanation of his positions. Meanwhile, news outlets report on how the gender gap and social issues like contraception are playing in this election cycle.
In an unprecedented show of concern, The Academy for Eating Disorders (AED), Binge Eating Disorder Association (BEDA), Eating Disorder Coalition (EDC), International Association for Eating Disorder Professionals (IADEP), and National Eating Disorder Association (NEDA) have joined forces and are urging focus on health and lifestyle rather than weight as a measurement of well-being.
› Verified 9 days ago
| Entity Name | Singing River Gulfport |
|---|---|
| Entity Type | Part B Supplier - Hospital Department(s) |
| Entity Identifiers | NPI Number: 1780312504 PECOS PAC ID: 5294154829 Enrollment ID: O20230106000462 |
News Archive
TetraLogic Pharmaceuticals announced today that the Company has completed dosing of the first cohort in a Phase 1 clinical trial of its selective SMAC mimetic, TL32711. The Phase 1 trial is an open-label, dose-escalation study evaluating the safety and tolerability of TL32711 in adults with solid tumors or lymphoma refractory to standard therapies. The study will also assess the pharmacokinetics, pharmacodynamics and anti-tumor activity of TL32711.
Ovarian cancer is the most deadly disease of the female reproductive system, with most cases diagnosed in later stages. Yet while ovarian cancer affects 1 in 70 women in the United States, many women have never discussed the risk with their doctor.
GOP Presidential hopeful Rick Santorum continued to press the parallels between the state law signed by his rival, former Massachusetts Gov. Mitt Romney, and the federal measure, as well as to question Romney's explanation of his positions. Meanwhile, news outlets report on how the gender gap and social issues like contraception are playing in this election cycle.
In an unprecedented show of concern, The Academy for Eating Disorders (AED), Binge Eating Disorder Association (BEDA), Eating Disorder Coalition (EDC), International Association for Eating Disorder Professionals (IADEP), and National Eating Disorder Association (NEDA) have joined forces and are urging focus on health and lifestyle rather than weight as a measurement of well-being.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Andrew J Zielinski, CRNA 2101 Highway 90, Gautier, MS 39553-5340 Ph: (228) 497-7576 | Andrew J Zielinski, CRNA 2809 Denny Ave, Pascagoula, MS 39581-5301 Ph: (228) 809-5540 |
News Archive
TetraLogic Pharmaceuticals announced today that the Company has completed dosing of the first cohort in a Phase 1 clinical trial of its selective SMAC mimetic, TL32711. The Phase 1 trial is an open-label, dose-escalation study evaluating the safety and tolerability of TL32711 in adults with solid tumors or lymphoma refractory to standard therapies. The study will also assess the pharmacokinetics, pharmacodynamics and anti-tumor activity of TL32711.
Ovarian cancer is the most deadly disease of the female reproductive system, with most cases diagnosed in later stages. Yet while ovarian cancer affects 1 in 70 women in the United States, many women have never discussed the risk with their doctor.
GOP Presidential hopeful Rick Santorum continued to press the parallels between the state law signed by his rival, former Massachusetts Gov. Mitt Romney, and the federal measure, as well as to question Romney's explanation of his positions. Meanwhile, news outlets report on how the gender gap and social issues like contraception are playing in this election cycle.
In an unprecedented show of concern, The Academy for Eating Disorders (AED), Binge Eating Disorder Association (BEDA), Eating Disorder Coalition (EDC), International Association for Eating Disorder Professionals (IADEP), and National Eating Disorder Association (NEDA) have joined forces and are urging focus on health and lifestyle rather than weight as a measurement of well-being.
› Verified 9 days ago
Amanda Graham Dobbins, CRNA Nurse Anesthetist - CR Medicare: Medicare Enrolled Practice Location: 2809 Denny Ave, Pascagoula, MS 39581 Phone: 228-806-4525 | |
Mr. Laird Miller, Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 2809 Denny Ave, Pascagoula, MS 39581 Phone: 228-809-5000 | |
Mr. Christopher Arlen Jones, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 2809 Denny Ave, Pascagoula, MS 39581 Phone: 228-809-5531 Fax: 228-809-1153 | |
Jonathan White, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 2809 Denny Ave, Pascagoula, MS 39581 Phone: 228-809-5000 | |
Mrs. Christine Cooper Bowman, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 2809 Denny Ave, Pascagoula, MS 39581 Phone: 228-809-5000 | |
Robert Shotlander, Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 2809 Denny Ave, Pascagoula, MS 39581 Phone: 228-809-5000 |